PPIB and galactosemia: The expansion is intended to implement the screening gradually, in five phases for (1) congenital toxoplasmosis (currently ongoing), (2) galactosemias, aminoacidopathies, urea cycle disorders, and disorders of fatty acid β-oxidation, (3) lysosomal diseases, (4) primary immunodeficiencies, and (5) 5q SMA, besides six diseases already screened in the current basic test.